The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

Authors
Citation
D. Grimwade, The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia, BEST P R C, 14(3), 2001, pp. 497-529
Citations number
172
Categorie Soggetti
Hematology
Journal title
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
ISSN journal
15216926 → ACNP
Volume
14
Issue
3
Year of publication
2001
Pages
497 - 529
Database
ISI
SICI code
1521-6926(200109)14:3<497:TCSOCA>2.0.ZU;2-E
Abstract
During the last three decades it has become apparent that the majority of c ases of acute myeloid leukaemia (AML) are characterized by at least one of a variety of recurrent chromosomal abnormalities. These changes have been f ound in many instances to correlate closely with distinct morphological fea tures and clinical characteristics, the molecular basis of which is becomin g increasingly understood. Furthermore, diagnostic karyotype has been shown to be a key determinant of outcome in AML, with mounting evidence to suppo rt the notion that cytogenetic analysis can serve to identify biologically distinct subsets of disease that demand tailored therapeutic approaches. Th is has led to a rising trend towards routine cytogenetic and molecular char acterization of newly diagnosed acute leukaemia, providing a framework for treatment stratification.